Pause operations: company temporarily curtailing operations while keeping return options open
Leave Suspension
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Pause operations: company temporarily curtailing operations while keeping return options open
Leave SuspensionJapanese pharmaceutical giant Takeda is considering selling its Russian plant that produces, Ninlaro (ixazomib), a treatment for patients with multiple myeloma as well as other drugs.
Japan’s Takeda suspends new clinical trials in Russia and halts new investments in Russia, Supplies of drugs and clinical trials will continue. Takeda has taken further action to discontinue activities in Russia that are not essential to maintaining supply of medicines to patients and providing ongoing support to employees. This includes suspending all new investments, suspending advertising and promotion, not initiating new clinical trials and stopping enrollment of new patients in ongoing clinical trials.